AUS
NZ
UK
CA
USA
IND
Healthcare
5 stocks that may benefit from Sunak’s new £1.4-bn investment fund
October 25, 2021 11:16 AM BST| By Priya BhandariHighlights The UK government is planning to launch a £1.4bn fund to attract more overseas investments. Over £800 million of the new investment fund will go to support production and supply chain of EVs. The UK government in a .....
100-300% return in a year! Should you buy these 2 AIM stocks?
October 22, 2021 11:43 AM BST| By Nidhi GuptaHighlights ValiRx inked a contract with a renowned London university to test new technology for the treatment of breast cancer. As per the terms of the contract, it will conduct preclinical tests on the drug candidate for nine months to validate.....
.jpg)
GSK & AZN: 2 dividend-paying pharma stocks for income investors
October 18, 2021 02:03 PM BST| By Nidhi GuptaThe UK pharmaceutical industry is a major global hub for the research, development and production of pharmaceuticals and also plays a crucial role in the country’s economy. Pharmaceutical companies gained heavily from the development and comm.....
GlaxoSmithKline (GSK): Should you hold it after split of headquarter?
October 11, 2021 03:23 PM BST| By Suhita PoddarHighlights GlaxoSmithKline announced plans for setting up two headquarters today, wherein its consumer healthcare business would have a new headquarter, and its existing pharma business will be relocated to another office. The HQ split is an im.....
Are these 2 pharma stocks good buy for long term growth?
October 08, 2021 11:49 AM BST| By Nidhi GuptaInvesting in pharmaceutical stocks is a growing trend, especially in times of political or economic uncertainty. For instance, during the Covid-19 crisis, pharmaceutical firms were in high demand as they offered medicines, products, and equipment n.....
.jpg)
Pfizer, J&J, AstraZeneca: What's the latest on Covid vaccines
October 06, 2021 07:14 AM BST| By Nidhi GuptaHighlights The US Food and Drug Administration approved the administration of a booster dose of the Pfizer/BioNTech vaccine in adults aged 65 years and above and others with a weak immune system. Johnson & Johnson requested for US FDA.....
.jpg)
Abingdon (ABDX) soars 39%. Is this covid-19 testing stock still a buy?
October 05, 2021 07:17 AM BST| By Suhita PoddarHighlights UK-based rapid test developer and maker Abingdon Health shares surged over 38 per cent on Monday, making it the highest riser on the LSE. The shares rose on reports that the company will soon start the manufacturing of a Covid saliva.....
.jpg)
Oxford Nanopore (ONT): What to expect after stellar listing?
October 01, 2021 10:29 AM BST| By Suhita PoddarUK based DNA sequencing biotechnology firm Oxford Nanopore Technologies PLC’s (LON: ONT) shares surged on listing on the LSE on Thursday, making it one of the best IPO debuts on the exchange. The company’s shares rose by over 45 per ce.....
.jpg)
Should you buy these pharma stocks with over 80% return in a year?
September 30, 2021 03:09 PM BST| By Nidhi GuptaHighlights For the half-year ended 30 June 2021, Oxford Biomedica’s revenue increased by 139% year-on-year to £81.3 million compared to £34.0 million in H1 2020. Indivior Plc’s operating profit for Q2 2021 increase.....
.jpg)
MyHealthChecked (M3HC) & Alliance (APH): Are these pharma stocks a buy now?
September 30, 2021 07:55 AM BST| By Nidhi GuptaHighlights MyHealthChecked had recently acquired Nell Health Ltd, a technology-led genetic-testing platform and provider of personalised nutrition solutions, for £1.2 million. Alliance Pharma declared an interim dividend of 0.563 pe.....
AstraZeneca (LON: AZN) to acquire Caelum Biosciences: Buy alert?
September 29, 2021 04:24 PM BST| By Suhita PoddarHighlights Anglo-Swedish pharma company, AstraZeneca’s Alexion is set to acquire the remaining stake in rare disease biotech firm Caelum Biosciences. The deal is worth up to US$ 150 million, with a potential facility for making additional.....
Sareum (SAR) returns 700% in a year: Is this small-cap share still a good buy?
September 13, 2021 03:35 PM BST| By Nidhi GuptaHIGHLIGHTS Saerum raised £2.37 million in June 2021 through two subscription contracts with high-net-worth individuals. In July 2021, the company received approval from the US Patent and Trademark Office for the use of SDC-1802 drug molec.....
.jpg)
Synairgen & Omega Diagnostics: 2 AIM pharma stocks for a healthy portfolio
September 09, 2021 08:34 AM BST| By Nidhi GuptaHighlights Omega Diagnostics filed for CE-mark on Covid-19 antigen self-test ‘Visitect’. Synairgen, last year generated £87.1 million to fund the SG018 Phase III trial. The exceptional pace of technological advancem.....
.jpg)
Open Orphan (ORPH) & Angle (AGL): 2 AIM pharma stocks to buy in September
September 06, 2021 01:21 PM BST| By Nidhi GuptaPharma stocks listed on AIM present attractive investment opportunities for investors seeking to diversify their portfolios, and they simultaneously offer ample growth prospects. AIM pharma stocks comprise smaller pharmaceutical companies that desi.....
UK may offer Covid-19 jabs to 12- 15-year-olds. Stocks to look at
September 01, 2021 09:24 AM BST| By Suhita PoddarHighlights NHS England to prepare for a potential extension of the Covid vaccination programme to all 12 to 15-year-olds from early September. No advice regarding vaccine rollout provided by JCVI yet, but forward planning to be started. .....
.jpg)
Faron (LON: FARN) & Novacyt (LON: NCYT) shares. Should you buy them now?
August 26, 2021 01:28 PM BST| By Kamalika GhoshHighlights Faron Pharmaceuticals Oy share prices suffered a sharp correction of around 7 per cent. For the H1 2021 ended 30 June 2021, Novacyt recorded revenues of £94.7 million, up by over 50% compared to £63.3 million in H1 .....
Inspira supports Vectura’s (LON: VEC) £1.1bn acquisition by Philip Morris
August 23, 2021 10:36 AM BST| By Kamalika GhoshHighlights Inspira Pharmaceuticals comes out to support Vecutra’s £1.1 billion takeover by US-based Philip Morris International amid rising criticism due to potential threats to the UN’s sustainability goals and future co.....
.jpg)
UK’s Psychedelic sector and potential investment opportunities
August 19, 2021 08:46 AM BST| By Kamalika GhoshHighlights Decades of research has shown Psychedelic substance such as LSD and Psilocybin can treat the mental disorder more efficiently than conventional therapies. The market size of the Psychedelic treatment was at USD five billion in 2020 a.....
Is it the right time to invest in these 5 FTSE listed cannabis stocks?
August 17, 2021 09:03 AM BST| By Kamalika GhoshVery recently, in 2018 the UK legalised the medicinal use of cannabis. Medical cannabis, which is used to treat the pain and specific illnesses was first legalised in the United states for the treatment of Alzheimer's disease and other medical cond.....
Pfizer booster shot - Which other vaccines may require booster doses?
August 10, 2021 12:38 PM BST| By Suhita PoddarSummary According to BioNTech, a booster shot of the two-shot Pfizer vaccine is expected to serve as a better strategy to fight new variant than altering the existing vaccine product. AstraZeneca is yet not sure if a booster dose of the C.....
